Rock Springs Capital Management LP Cytokinetics Inc Transaction History

Rock Springs Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $10.6 Million - $12.4 Million	206,108 New	206,108 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $9.23 Million - $11.5 Million	-313,348 Reduced 70.01%	134,252 $3.96 Million
Q1 2023 May 15, 2023	BUY	$33.36 - $45.71 $153,456 - $210,266	4,600 Added 1.04%	447,600 $15.8 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.66 Million - $2.34 Million	43,000 Added 10.75%	443,000 $21.5 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $13.6 Million - $19.6 Million	400,000 New	400,000 $15.7 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $3.15 Million - $5.91 Million	-206,495 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $2.66 Million - $3.74 Million	129,078 Added 166.73%	206,495 $4.47 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $863,199 - $1.91 Million	77,417 New	77,417 $1.83 Million

397

122M

3.46M

1.86M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.33B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.